BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 22, 2006
View Archived Issues
Combined intravenous/intraarterial rt-PA assessed in ischemic stroke patients
Read More
Piracetam protects against cognitive impairment after coronary artery bypass grafting
Read More
Encouraging phase I results for rotavirus vaccines
Read More
MDS Nordion to supply Zemiva to Molecular Insight Pharmaceuticals
Read More
King and Arrow collaborate on new formulations of Altace
Read More
Diversa and BASF establish broad alliance to develop new products
Read More
Targeted CCR5 gene disruption renders human primary cells resistant to HIV
Read More
Novel class of allosteric Bcr-Abl inhibitor that potentiates imatinib
Read More
Nitrite infiltrations provide neuroprotective benefits in brain ischemia
Read More
Antitumor effects of targeting thioredoxin
Read More
Numerous agents under investigation in pancreatic and hepatic cancer
Read More
BCY and Pipex complete business combination discussions
Read More
CSL reports encouraging results from Australian pandemic influenza vaccine trial
Read More
Kyorin signs license agreement with Novartis for immunomodulator KRP-203
Read More
U.S. BioDefense validates human neural crest stem cells
Read More
Fispemifene begins phase II trial to treat symptoms of andropause
Read More
Dosing begins in phase III study of ospemifene for vaginal atrophy
Read More
Planned Oxycyte phase II trial placed on hold for protocol revisions
Read More
Recruitment interrupted in phase III trial of Neovastat in NSCLC
Read More
Bristol-Myers Squibb strengthens Tequin warnings
Read More
Relenza approved for children aged five or older in Japan
Read More
Novel agents for treating neurological disorders disclosed in recent patent literature
Read More
U.S. launch of Ultram ER
Read More
Eraxis approved to treat candidemia
Read More
Sweden approves Multiferon in malignant melanoma
Read More
Recent Roche patent reports novel therapeutics for HIV infection
Read More
Recent patents reveal novel antidiabetic agents
Read More
The antipsychotic drug trifluoperazine may be useful to prevent opioid tolerance
Read More